Syringe And Needle Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, UK, India, France, Japan, Canada, Australia, Brazil - Size and Forecast 2024-2028

Syringe And Needle Market Size 2024-2028

The syringe and needle market size is forecast to increase by USD 10.96 billion at a CAGR of 8% between 2023 and 2028.

• The market encompasses various types of syringes, including ophthalmic, bone marrow, and catheter syringes, which find applications in general surgery, diagnostic, and respiratory applications within the healthcare system. Market growth is driven by the increasing prevalence of critical care conditions and innovations in pre-filled syringes. However, competition from alternative drug delivery systems poses a challenge to market growth. Disposable syringes dominate the market due to their convenience and ease of use, while reusable syringes continue to be used in specific applications, such as orthopedic surgeries. The healthcare products industry is continually evolving, with a focus on improving patient safety and reducing healthcare costs. This market analysis report provides an in-depth examination of these trends and challenges in the market.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

• The market holds a pivotal role in the healthcare industry, particularly in the context of drug delivery technology. This market caters to the requirements of hospitals and healthcare systems for various applications, including pre-filled syringes (PFS) for vaccinations and chronic therapies. Vaccinations are a crucial aspect of preventive healthcare, especially in the face of infectious diseases and long-term conditions such as diabetes, cardiovascular diseases, and cancer. The World Health Organization (WHO) focuses on the importance of vaccines in disease prevention and control and the need for a reliable and efficient market to ensure the availability of vaccine doses. The market also plays a significant role in the delivery of injectable drugs for chronic diseases like diabetes. Moreover, the market caters to the needs of outpatient treatments, ensuring safety and effectiveness in the administration of injectable drugs. The geriatric population, a growing demographic, benefits greatly from these advancements, as they are more susceptible to chronic diseases and long-term therapies. Safety is a primary concern in the market, with a focus on reducing needle stick injuries and minimizing the risk of viral transmission.

• This is especially important in the context of hospitals and healthcare facilities, where large volumes of injections are administered daily. The Asia Pacific markets represent a substantial growth opportunity for the market, driven by the increasing prevalence of long-term diseases and the need for injectable development in this region. The market is expected to witness steady growth, fueled by advancements in drug delivery technology and the increasing demand for vaccines and chronic disease management. In conclusion, the market plays a vital role in addressing the vaccination needs and long-term disease management requirements of healthcare systems. Its significance is underscored by the increasing prevalence of chronic diseases and the need for effective and safe drug delivery technology. The market's continued growth is expected to contribute positively to the healthcare industry, ensuring the availability of essential vaccines and injectable drugs for the global population.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Hospitals and clinics
  • Home care
  • Others
• Product
  • Syringe
  • Needle
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

By End-user Insights

• The hospitals and clinics segment is estimated to witness significant growth during the forecast period.

In the healthcare sector, syringes and needles, specifically Ophthalmic Syringes, Bone Marrow Syringes, and Catheter Syringes play a significant role in various applications. Hospitals and clinics are the primary consumers of these healthcare products due to their essential use in administering medications, including vaccines, anticoagulants, and biologics. The benefits of using syringes and needles for drug delivery are numerous. They ensure ease of administration, precise dosing, and extended storage time, making them a preferred choice for healthcare professionals. The European Board of Anaesthesiology (EBA), the National Patient Safety Agency, and the Association of Anaesthetists of Great Britain and Ireland advocate for the use of syringes and needles in all possible applications.

Furthermore, disposable syringes and reusable syringes are both widely used in the healthcare system, depending on the specific application and cost considerations. Syringes and needles find extensive use in general surgery, diagnostics, and respiratory applications. In orthopedics, for instance, bone marrow aspiration syringes are indispensable. Diagnostic applications include collecting samples for laboratory tests, while respiratory applications involve administering medications through nebulizers. In conclusion, the market caters to diverse healthcare needs, with hospitals and clinics being the primary consumers. The benefits of using syringes and needles for drug delivery, such as ease of administration, precise dosing, and extended storage time, make them an indispensable part of the healthcare system.

Get a glance at the market report of share of various segments Request Free Sample

The hospitals and clinics segment was valued at USD 8.09 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 30% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The market is witnessing notable expansion due to several factors, including regulatory advancements, expanded production capacities, and escalating demand for medical equipment. A pivotal development in this region is BD (Becton, Dickinson and Company)'s reaction to the U.S. Food and Drug Administration's (FDA) Safety Alert issued on March 19, 2024. This alert highlights the FDA's ongoing assessment of specific plastic syringes, emphasizing the importance of heightened safety and dependability in medical devices. Following the FDA's initial safety alert in November 2023, BD has substantially increased its domestic manufacturing capacity to address these concerns.

Furthermore, this move underscores the company's commitment to ensuring the safety and reliability of its products, particularly in the context of conditions like Type 2 diabetes, cardiac disorders including Coronary Artery Disease, and Heart attacks, for which syringes and needles are essential. Furthermore, the geriatric population's growing need for safety syringes and the increasing demand for vaccines add to the market's expansion. The hereditary angioedema patient population also relies on these devices for treatment, further fueling market growth. Enhanced safety features, such as needle guard mechanisms, are increasingly being adopted to minimize needle stick injuries. This market trend is expected to continue as the focus on patient safety and well-being remains a top priority.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Syringe And Needle Market?

Growing demand for syringes and needles for biologic therapies is the key driver of the market.

• The market in the healthcare sector is witnessing substantial expansion due to the rising demand for injectable developments, particularly in the area of biological therapies. These therapies, which cater to conditions such as Crohn's disease, atopic dermatitis, cardiovascular diseases, and various rare diseases, necessitate specialized delivery systems.

• In response to this growing market trend, BD, a leading medical technology company, introduced the BD Neopak XtraFlow Glass Prefillable Syringe in September 2024. This innovative product, alongside the expansion of BD's Neopak Glass Prefillable Syringe platform, signifies the industry's commitment to addressing the stringent requirements of biologic drug delivery. Healthcare institutions, clinical centers, medical research laboratories, consulting firms, and other usability segments are increasingly adopting sterilizable hypodermic syringes and oral syringes to ensure the safe and effective administration of these advanced therapies.

What are the market trends shaping the Syringe And Needle Market?

Innovations in pre-filled syringes are the key trend in the market.

• Pre-filled syringes have become essential components in the delivery of various medications, particularly for vaccinations and long-term diseases such as infectious diseases, cardiovascular disease, diabetes, and cancer. Drug delivery technology continues to evolve, with manufacturers focusing on enhancing safety and efficiency. Some pre-filled syringe manufacturers offer integrated automatic needle shielding and retractable needles.

• Moreover, advancements in production techniques, such as automated machines, enable manufacturers to produce over ten thousand pre-filled syringes at a time, ensuring a steady supply for hospitals and healthcare providers. Manufacturers are also focusing on reducing silicone content in pre-filled syringes to make them safer. These efforts demonstrate the commitment of the industry to provide effective and reliable drug delivery solutions to meet the growing vaccination needs and manage various health conditions. Thus, such trends will shape the growth of the market during the forecast period.

What challenges does Syringe And Needle Market face during the growth?

Stringent government regulations is a key challenge affecting the market growth.

• The market is subject to rigorous regulations set by the Food and Drug Administration (FDA) to ensure the safety and effectiveness of medical devices. In December 2023, the FDA investigated the quality of plastic syringes manufactured in China, raising concerns about their performance and safety, particularly their ability to accurately deliver the intended dose of medication when used alone or in combination with other medical devices.

• This regulatory scrutiny poses a significant challenge for manufacturers, who must consistently meet stringent standards to guarantee the safety of their products. Types of syringes available in the market include Conventional Syringes, Retractable Safety Syringes, Non-Retractable Safety Syringes, Prefilled Syringes, Glass Syringes, and Plastic Syringes. These syringes cater to various applications, such as General Syringes and Specialized Syringes, including Insulin Syringes. Manufacturers must navigate these regulatory requirements to maintain market competitiveness and consumer trust.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Angiplast Pvt Ltd
• APEX MEDICAL DEVICES
• B.Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• Cardinal Health Inc.
• Cartel Healthcare Pvt. Ltd.
• Gerresheimer AG
• Henry Schein Inc.
• Hi Tech Medics Pvt Ltd.
• Hindustan Syringes and Medical Devices Ltd.
• ICU Medical Inc.
• ISCON SURGICALS LTD
• Keeler Ltd.
• Nipro Corp.
• Shanghai Mekon Medical Devices Co Ltd.
• Teleflex Inc.
• Terumo Europe NV
• Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The market encompasses a wide range of products used for drug delivery and diagnostic applications in various healthcare settings. From pre-filled syringes for vaccinations and chronic therapies to blood collection syringes, ophthalmic syringes, bone marrow syringes, catheter syringes, and more, these essential healthcare products cater to the needs of hospitals, clinical centers, medical research laboratories, and consulting firms. The demand for syringes and needles is driven by the increasing prevalence of long-term diseases such as diabetes, cardiovascular diseases, cancer, and infectious diseases. According to the World Health Organization, an estimated 422 million people have diabetes worldwide, and over 17 million new cases are diagnosed each year.

Furthermore, insulin administration through insulin syringes is a common treatment for diabetes mellitus, ensuring blood sugar control for type 2 diabetes patients. In the context of cardiovascular diseases, coronary artery disease and heart attacks are significant contributors to morbidity and mortality. Hypodermic syringes and reusable or disposable needles are commonly used for administering injectable drugs, including cardiac medications, to manage these conditions. Moreover, the geriatric population, with its higher susceptibility to various chronic diseases, also fuels the demand for safety syringes to minimize needle stick injuries during vaccinations and other treatments. The healthcare system's focus on outpatient treatments and diagnostic applications, such as respiratory applications and orthopedics, further expands the market scope.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch